Blinatumomab
About
Therapy type: Immunotherapy
Therapy strategy: CD19 inhibition
Mappings
NCI Thesaurus: Blinatumomab (coding:ncit:C62528)
RxNorm: blinatumomab (coding:rxcui:1597258, coding:omop:45892531)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) FDA (4) | CD19 + | Acute Lymphoblastic Leukemia | Blinatumomab | |
| EMA (5) FDA (2) | CD19 +, not BCR::ABL1 | Acute Lymphoblastic Leukemia | Blinatumomab |